The UCSF Industry Documents Library released another 519,000 new Juul Labs documents, bringing the total number of documents to 1,053,233. This is about one-quarter of the complete collection of more than 4 million documents. Check out the Juul documents here.
Category Archives: vaping
NOW OPEN ACCESS: E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone
NEJM Evidence has graciously made our recent paper, “Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes,” open access so that anyone can read and download it for free. As described in more detail in my blog post on the paper, it uses data from 107 population epidemiology studies of the association between e-cigaretteContinue reading “NOW OPEN ACCESS: E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”
Contrary to public position, Juul founders wanted to attract former and non-smokers from the beginning
Juul co-founders Adam Monsees and James Bowen portray themselves as idealistic entrepreneurs committed to improving the health of billions of adult smokers with no intent to sell nicotine to non-smokers. Documents released as part of the settlement of North Carolina’s lawsuit against Juul, however, tells quite a different story. In particular, Monsees & Bowen’s 2006Continue reading “Contrary to public position, Juul founders wanted to attract former and non-smokers from the beginning”
5 year longitudinal study finds e-cigs and cigs have similar risks for respiratory disease and COPD; dual use is worse
Beibei Song and colleagues’ new paper, Impact of electronic cigarette usage on the onset of respiratory symptoms and COPD among Chinese adults, finds that e-cigarettes and cigarettes pose similar risks for causing respiratory symptoms and chronic obstructive disease (COPD) in Chinese adults. Dual use is worse than using either product alone. This is a veryContinue reading “5 year longitudinal study finds e-cigs and cigs have similar risks for respiratory disease and COPD; dual use is worse”
British smokers understand risks of e-cig use better than a lot of British health officials and scientists
England remains the country in which the government and (most of the) health establishment continue to aggressively promote e-cigarettes as a better alternative to cigarettes. As a result, Sarah Jackson and her colleagues were concerned about the results of their latest survey of smokers’ attitudes towards e-cigarettes, reported in their paper Trends in Harm PerceptionsContinue reading “British smokers understand risks of e-cig use better than a lot of British health officials and scientists”
More information on how ecigs increase cardiovascular disease risk
The evidence that e-cigarette use is associated with increased cardiovascular disease keeps accumulaing, together with studies on the specific pathophysiological mechanisms through which e-cigarette use increases disease risk. The recent review by Huiqi Zong, Zhekai Hu and colleagues, Electronic cigarettes and cardiovascular disease: epidemiological and biological links, is the most recent summary of this evidence.Continue reading “More information on how ecigs increase cardiovascular disease risk”
Juul’s internal playbook opens a rare window into influence in Washington
Nicholas Florko at StatNews just published an excellent piece using the newly-released Juul internal documents to describe how the company worked behind the scenes in Washington all the way down to local governments to influence, legislators, the Administration, regulatory agencies, local governments and public opinion generally by campaign contributions, quietly hiring a range of politicalContinue reading “Juul’s internal playbook opens a rare window into influence in Washington”
FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes
As of February 22, 2024, the FDA was continuing to embrace the idea that there is a “continuum of risk” with combusted tobacco as the riskiest and e-cigarettes being substantially less risky. As a result, FDA promotes e-cigarettes as a way for smokers to reduce risk. This view is based on the fact that e-cigarettesContinue reading “FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes”
E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone
It is an article of faith among e-cigarette advocates that they are substantially less risky than cigarettes. Rather than being based on the actual associations between e-cigarette use and disease, this belief is based on the fact that e-cigarettes do not burn tobacco, so avoid the toxic combustion products that cigarettes produce. In recent years,Continue reading “E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”
Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame
Yogi Hendlin, Eileen Han and Pam Ling’s new paper Pharmaceuticalisation as the tobacco industry’s endgame provides a detailed analysis of how the multinational tobacco companies have developed and used the companies efforts to reposition themselves a source for “clean” nicotine while simultaneously maintaining and expanding their sales of cigarettes and other “traditional” tobacco products whereContinue reading “Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame”
Stanton Glantz blog 